|
|
|
|
| LEADER |
01719nam a2200373 u 4500 |
| 001 |
EB001999350 |
| 003 |
EBX01000000000000001162251 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 9781587631351
|
| 020 |
|
|
|a 1587631350
|
| 100 |
1 |
|
|a Shekelle, Paul G.
|
| 245 |
0 |
0 |
|a Ephedra and ephedrine for weight loss and athletic performance enhancement
|h Elektronische Ressource
|b clinical efficacy and side effects
|c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Southern California-RAND Evidence-Based Practice Center ; Paul Shekelle ... [et. al.]
|
| 260 |
|
|
|a Rockville, MD
|b U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality
|c 2003, [2002]
|
| 300 |
|
|
|a 2 v.
|b ill.
|c 28 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (p. 207-213)
|
| 505 |
0 |
|
|a v. 1. Evidence report and evidence tables -- v. 2. Appendixes
|
| 653 |
|
|
|a Ephedra
|
| 653 |
|
|
|a Clinical Trials as Topic
|
| 653 |
|
|
|a Weight Loss
|
| 653 |
|
|
|a Ephedrine / adverse effects
|
| 653 |
|
|
|a Evidence-Based Medicine
|
| 653 |
|
|
|a Doping in Sports
|
| 653 |
|
|
|a Risk Assessment
|
| 653 |
|
|
|a Ephedrine / therapeutic use
|
| 710 |
2 |
|
|a Southern California Evidence-Based Practice Center/RAND.
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Evidence report/technology assessment
|
| 500 |
|
|
|a "March 2003."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK36915
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|